Nimotuzumab plus gemcitabine prolongs survival in KRAS wild-type pancreatic cancer

Press/Media

Period	3 Jun 2022

Media coverage

Title	Nimotuzumab plus gemcitabine prolongs survival in KRAS wild-type pancreatic cancer
Media name/outlet	Healio
Country/Territory	United States
Date	3/06/22
URL	https://www.healio.com/news/hematology-oncology/20220603/nimotuzumab-plus-gemcitabine-extends-survival-in-kras-wildtype-pancreatic-cancer
Persons	Deirdre Cohen